Investing-News.Com
Information for Investors

CUBIST PHARMACEUT, (CBST) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

CUBIST PHARMACEUT, (CBST) Stock Rating Learn More

Our Overall Rating on Cubist Pharmaceuticals Inc,  CBST is BUY
StockPickReport.Com research suggests CBST's price will move higher than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

With StockPickReport.Com's "Buy" rating, stochastic and "relative strength" numbers may agree, but not in all cases.

Investors, traders, and other market participants may find this a good opportunity to buy CBST, "buy calls", or "sell puts".

This may also be an opportunity to raise targets and stop/losses to allow for potential gains (although those gains may not be as signficant as gains experienced in conjunction with a "Strong Buy" rating).

Trading volume seems to be falling and CBST's closing price moved down during the week before this rating was initiated.

Our BUY Rating on CBST was issued on 03/25/08

CUBIST PHARMACEUT Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces CUBIST PHARMACEUT Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in CUBIST PHARMACEUT buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on CUBIST PHARMACEUT. This software is specially designed to give precision entry and exit points on CUBIST PHARMACEUT, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When CUBIST PHARMACEUT Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even CUBIST PHARMACEUT, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: breaking stock news  stock market symbol  channel forex trading  louis navelliers blue chip growth letter 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Top 5 Mid-Caps for Nov. 20 (at TheStreet.com)

Targanta shares plummet on negative FDA panel vote (AP)

FDA panel: Theravance antibiotic safe, effective (AP)

[$$] Recession or Not, We Still Need Drugs (at RealMoney by TheStreet.com)

Top 5 Fast-Growth Stocks for Nov. 17 (at TheStreet.com)

CUBIST PHARMACEUTICALS INC Financials (EDGAR Online Financials)

Drug Maker Targets Infections That Are Resistant To Antibiotics (Investor's Business Daily)

Gurus Trade Out Of OptionsXpress (at Forbes.com)

CUBIST PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)

The Boston Globe names Cubist to Globe 100's Top Places to Work '08 (Business Wire)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.